Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-01-25FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (NorthStar Rx LLC)
FDA approved an original generic application for fluoxetine hydrochloride from NorthStar Rx LLC. Fluoxetine hydrochloride is used to treat m…
-
FDA approval · 2019-01-24FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s generic Bupropion Hydrochloride XL as an extended-release antidepressant under an ANDA supplement…
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Preventing Depression in Late Life: A Model for Low and Middle Income Countries [NA]
Completed clinical trial evaluating prevention strategies for depression in older adults in low- and middle-income countries; results were p…
-
CLINICAL_TRIALS research · 2019-01-24Clinical Trial Update: Does a Phone-based Meditation Application Improve Mental Wellness in Emergency Medicine Personnel? [NA]
A clinical trial examining whether a phone-based meditation app can improve mental wellness in emergency medicine personnel, focusing on bur…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Comparison of Anyu Peibo With Placebo in Treatment of MDD，Ⅱb [Phase 2]
A Phase 2 trial comparing Anyu Peibo to placebo for Major Depressive Disorder has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2019-01-22Clinical Trial Update: Early Family-Centered Prevention of Drug Use Risk (Aka Early Steps) [NA]
Completed clinical trial update on Early Steps, a family-centered prevention program to reduce drug-use risk. The study explored outcomes re…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome [Phase 2, Phase 3]
Clinical trial evaluating melatonin for depression, anxiety, circadian and sleep disturbances in patients after acute coronary syndrome has …
-
FDA approval · 2019-01-11FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Celexa (citalopram) submitted by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Cognitive Dysfunction in MDD Patients [Phase 4]
Phase 4 clinical trial update investigating cognitive dysfunction in patients with Major Depressive Disorder.
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology
Completed clinical trial investigating cognitive and mood assessment data in major depressive disorder using digital wearable technology; re…
-
FDA approval · 2019-01-10FDA Approved: FLUOXETINE — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved ScieGen Pharmaceuticals' original abbreviated new drug application for fluoxetine hydrochloride (generic fluoxetine), authorizi…
-
CLINICAL_TRIALS trial_result · 2019-01-07Clinical Trial Update: Realizing Opportunities for Self Empowerment [NA]
A completed trial studying self-empowerment for Depression; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-12-28Clinical Trial Update: Magnetic Brain Stimulation for the Treatment of Adult Depression [Phase 2, Phase 3]
Clinical trial update on magnetic brain stimulation for adult depression with completed Phase 2 and Phase 3 results.
-
FDA approval · 2018-12-27FDA Approved: TRIMIPRAMINE MALEATE — Supplemental Application (Elite Laboratories, Inc.)
FDA approved a supplemental application for trimipramine maleate from Elite Laboratories, Inc., effectively approving a change to an existin…
-
CLINICAL_TRIALS trial_result · 2018-12-26Clinical Trial Update: Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression [Phase 2]
Phase 2 trial update investigating moderators and biosignatures of antidepressant response for depression completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-26Clinical Trial Update: Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD [Phase 4]
Phase 4 trial evaluating the effectiveness of scopolamine combined with escitalopram in patients with major depressive disorder has complete…
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorder
Clinical trial update on Fevarin® (fluvoxamine) effectiveness in treating depression in patients with a neurological disorder; study complet…
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: A Long-Term Safety Study of ALKS 5461 [Phase 3]
Phase 3 long-term safety study of ALKS 5461 for major depressive disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy [NA]
Clinical trial on improving mental health outcomes through an adaptive implementation strategy has terminated; results posted in 2018.
-
FDA approval · 2018-11-23FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Marlex Pharmaceuticals, Inc.)
FDA approved a generic venlafaxine hydrochloride product from Marlex Pharmaceuticals, marking the first original ANDA approval for this gene…
-
CLINICAL_TRIALS research · 2018-11-21Clinical Trial Update: Technology Assisted Programs That Promote Mental Health for Teenagers [NA]
A completed clinical trial evaluating technology-assisted programs aimed at promoting mental health in teenagers with depression; results po…
-
FDA approval · 2018-11-21FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA granted approval for the original application of a generic fluoxetine hydrochloride product.
-
FDA approval · 2018-11-21FDA Approved: VENLAFAXINE — Original Application (Cadila Pharmaceuticals Limited)
FDA approved the original generic application for venlafaxine from Cadila Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Attention Bias Modification Training for Young People [NA]
Clinical trial update on Attention Bias Modification Training for anxiety and depression in young people; study completed with results poste…
-
FDA approval · 2018-11-19FDA Approved: OLANZAPINE — Original Application (HEC Pharm USA Inc.)
The FDA approved the original ANDA application for olanzapine, granting generic status to HEC Pharm USA Inc. for this antipsychotic drug.